InMode Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
660
- Stock Symbol
-
INMD
- Investments
-
1
- Share Price
-
$13.27
- (As of Friday Closing)
InMode General Information
Description
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Contact Information
Website
www.inmodemd.comCorporate Office
- 17 Hughes
- Irvine, CA 92618
- United States
Corporate Office
- 17 Hughes
- Irvine, CA 92618
- United States
InMode Stock Performance
As of 13-Nov-2026, InMode’s stock price is $13.27. Its current market cap is $764M with 57.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $13.27 | $13.19 | $12.72 - $16.67 | $764M | 57.5M | 518K | $1.22 |
InMode Financials Summary
As of 30-Sep-2026, InMode has a trailing 12-month revenue of $374M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 318,737 | 401,827 | 593,789 | 1,178,806 |
| Revenue | 373,598 | 370,495 | 394,818 | 492,048 |
| EBITDA | 66,572 | 86,082 | 113,259 | 196,283 |
| Net Income | 74,514 | 93,831 | 181,275 | 197,919 |
| Total Assets | 740,475 | 766,429 | 785,667 | 863,286 |
| Total Debt | 3,576 | 8,227 | 7,822 | 9,017 |
InMode Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InMode Comparisons
Industry
Financing
Details
InMode Competitors (12)
One of InMode’s 12 competitors is Sisram Medical, a Formerly PE-Backed company based in Caesarea, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sisram Medical | Formerly PE-Backed | Caesarea, Israel | ||||
| IRIDEX | Formerly VC-backed | Mountain View, CA | ||||
| Cutera | Formerly VC-backed | Brisbane, CA | ||||
| Cynosure (Other Devices and Supplies) | Private Equity-Backed | Westford, MA | ||||
| Teleflex | Corporation | Wayne, PA |
InMode Patents
InMode Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260096722-A1 | Fractional treatment of cervix | Pending | 08-Oct-2024 | ||
| US-20250288352-A1 | Combined rf fractional and non-fractional treatment | Pending | 14-Mar-2024 | ||
| US-12788485-B2 | Rf fractional device with uniform effect around the conductive elements | Active | 19-Feb-2024 | ||
| US-20240407833-A1 | Method and device for fractional fat treatment | Pending | 06-Jun-2023 | ||
| US-12397155-B2 | Method for treatment of erectile dysfunction | Active | 03-Nov-2022 | A61N1/36007 |
InMode Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
InMode Investments (1)
InMode’s most recent deal was a Corporate Asset Purchase with Viveve Medical (Intellectual Property Assets). The deal was made on 25-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Viveve Medical (Intellectual Property Assets) | 25-Jul-2023 | Corporate Asset Purchase | Buildings and Property |
InMode ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
30.58 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
InMode FAQs
-
When was InMode founded?
InMode was founded in 2008.
-
Where is InMode headquartered?
InMode is headquartered in Irvine, CA.
-
What is the size of InMode?
InMode has 660 total employees.
-
What industry is InMode in?
InMode’s primary industry is Other Devices and Supplies.
-
Is InMode a private or public company?
InMode is a Public company.
-
What is InMode’s stock symbol?
The ticker symbol for InMode is INMD.
-
What is the current stock price of InMode?
As of 13-Nov-2026 the stock price of InMode is $13.27.
-
What is the current market cap of InMode?
The current market capitalization of InMode is $764M.
-
What is InMode’s current revenue?
The trailing twelve month revenue for InMode is $374M.
-
Who are InMode’s competitors?
Sisram Medical, IRIDEX, Cutera, Cynosure (Other Devices and Supplies), and Teleflex are some of the 12 competitors of InMode.
-
What is InMode’s annual earnings per share (EPS)?
InMode’s EPS for 12 months was $1.22.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
